Study Of Drug Prescribing Practises In Tertiary Care Teaching Hospitals For Patients With Copd

Abstract

Chronic obstructive pulmonary disease, a common and possibly curable illness, has been a significant public health issue in this decade and is one of the leading causes of death and morbidity in industrialised and developing countries. A significant issue in modern clinical practise is the irrational use of medications; more than half of all pharmaceuticals are delivered through illicit dispensing. An investigation into the practise of medication prescription for patients with lung illness was the goal of this retrospective study.  The study was conducted over a six-month period, from June 2019 to December 2019, in 154 patients of either sex admitted to the general and pulmonary medicine departments at Royal Care Super Specialty Hospital, Tamilandu. Male participants made up the majority of the study's 154 participants (77.92%), and the majority of the patients were in the 58–68 age range (46.75 percent). The sample population has been shown to have a higher prevalence of smoking (40.25 per cent). In the treatment of COPD, bronchodilators (39.384 percent) and antibiotics were the two medication classes most frequently recommended (30.90 percent). In the majority of prescriptions, salbutamol and budesonide combination treatment was used. The much more common co-morbidity was hypertension (12.98 per cent). The prescriptions for generic drugs were found to be low (1.51 per cent drugs). The report found that our hospital provided symptomatic treatment for patients with COPD. This has chosen combination therapy over monotherapy. Bronchodilators were amongst COPD patients the most recommended class of medications. Both patients were administered antimicrobial therapy. Everything prescriptions contain polypharmaceutical. COPD diagnosis lacked spirometry.